Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

[1]  D. Mankuta,et al.  Maternal anxiety, mother-infant interactions, and infants' response to challenge. , 2010, Infant behavior & development.

[2]  N. Day,et al.  Trait anxiety in pregnant women predicts offspring birth outcomes. , 2009, Paediatric and perinatal epidemiology.

[3]  T. Henriksen,et al.  Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. , 2009, Archives of pediatrics & adolescent medicine.

[4]  E. Gilboa-Schechtman,et al.  Maternal depression and anxiety across the postpartum year and infant social engagement, fear regulation, and stress reactivity. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  Sabine J. Roza,et al.  Maternal psychological distress and fetal growth trajectories: The Generation R Study , 2009, Psychological Medicine.

[6]  Kelan Thomas,et al.  Pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions , 2009, Pharmacotherapy.

[7]  Xiao-hong Ma,et al.  Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response , 2009, Psychopharmacology.

[8]  T. Lehtimäki,et al.  MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs , 2009, European Neuropsychopharmacology.

[9]  Abraham Weizman,et al.  Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes , 2009, Pediatric Research.

[10]  Abraham Weizman,et al.  Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. , 2008, Pharmacogenomics.

[11]  Paul B van den Berg,et al.  Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. , 2008, British journal of clinical pharmacology.

[12]  B. Condron,et al.  Developmental effects of SSRIs: lessons learned from animal studies , 2007, International Journal of Developmental Neuroscience.

[13]  W. Ray,et al.  Increasing use of antidepressants in pregnancy. , 2007, American journal of obstetrics and gynecology.

[14]  P. Reebye,et al.  Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. , 2006, The American journal of psychiatry.

[15]  L. Sirota,et al.  Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. , 2006, Archives of pediatrics & adolescent medicine.

[16]  O. Spigset,et al.  Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy , 2005, Drug safety.

[17]  R. Grunau,et al.  Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure , 2005, Pediatrics.

[18]  T. Oberlander,et al.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. , 2004, The Journal of clinical psychiatry.

[19]  P. S. Zeskind,et al.  Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. , 2004, Pediatrics.

[20]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[21]  D. Stewart,et al.  Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. , 2002, The American journal of psychiatry.

[22]  P. Cairns,et al.  Hypernatraemia: why bother weighing breast fed babies? , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[23]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[24]  W. Frankenburg,et al.  Reliability and stability of the Denver Developmental Screening Test. , 1971, Child development.

[25]  S. Marcus.  Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008. , 2009, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[26]  J. Friedman,et al.  Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy , 2009, CNS drugs.

[27]  P. Merlob,et al.  Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. , 2008, The Israel journal of psychiatry and related sciences.

[28]  P. Reebye,et al.  Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. , 2007, Archives of pediatrics & adolescent medicine.

[29]  N. M. Nelson.  Current therapy in neonatal-perinatal medicine , 1990 .

[30]  I. Heuser,et al.  The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. , 1988, Journal of affective disorders.

[31]  G. Nellhaus.  Head circumference from birth to eighteen years. Practical composite international and interracial graphs. , 1968, Pediatrics.